MITOCHONDRIAL METABOLIC REPROGRAMMING OF MELANOMA CELLS EXPOSED TO BRAFV600E INHIBITOR

被引:0
|
作者
Kluza, J. [1 ]
Jendoubi, M. [1 ]
Corazao-Rozas, P. [1 ]
Andre, F. [1 ]
Jonneaux, A. [1 ]
Guerreschi, P. [1 ]
Formstecher, P. [1 ]
Mortier, L. [1 ]
Marchetti, P. H. I. [1 ]
机构
[1] INSERM, U837, Eq4, F-59045 Lille, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:30 / 30
页数:1
相关论文
共 50 条
  • [1] Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib-resistant BRAFV600E mutation bearing metastatic melanoma cells
    Carpenter, Evan L.
    Chagani, Sharmeen
    Nelson, Dylan
    Cassidy, Pamela B.
    Laws, Madeleine
    Ganguli-Indra, Gitali
    Indra, Arup K.
    [J]. MOLECULAR CARCINOGENESIS, 2019, 58 (09) : 1680 - 1690
  • [2] BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma
    J S Wilmott
    A M Menzies
    L E Haydu
    D Capper
    M Preusser
    Y E Zhang
    J F Thompson
    R F Kefford
    A von Deimling
    R A Scolyer
    G V Long
    [J]. British Journal of Cancer, 2013, 108 : 924 - 931
  • [3] BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma
    Wilmott, J. S.
    Menzies, A. M.
    Haydu, L. E.
    Capper, D.
    Preusser, M.
    Zhang, Y. E.
    Thompson, J. F.
    Kefford, R. F.
    von Deimling, A.
    Scolyer, R. A.
    Long, G. V.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (04) : 924 - 931
  • [4] The BRAFV600E kinase inhibitor vemurafenib induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E mutated melanoma cells
    Beck, D.
    Niessner, H.
    Flaherty, K.
    Vasseur, S.
    Iovanna, J. L.
    Bauer, J.
    Weide, B.
    Kulms, D.
    Schadendorf, D.
    Garbe, C.
    Meier, F.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 (09): : 792 - 792
  • [5] Mitochondrial Localization and Regulation of BRAFV600E in Thyroid Cancer: A Clinically Used RAF Inhibitor Is Unable to Block the Mitochondrial Activities of BRAFV600E
    Lee, Min Hee
    Lee, Seong Eun
    Kim, Dong Wook
    Ryu, Min Jeong
    Kim, Sung Jin
    Kim, Sung Joong
    Kim, Yong Kyoung
    Park, Ji Hoon
    Kweon, Gi Ryang
    Kim, Jin Man
    Lee, Jung Uee
    De Falco, Valentina
    Jo, Young Suk
    Shong, Minho
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (01): : E19 - E30
  • [6] cAMP signaling in BRAFV600E melanoma
    Rodriguez, Carlos I.
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [7] BRAFv600E INHIBITOR(VEMURAFENIB) IN PEDIATRIC PATIENTS AFFECTED BY BRAFv600E MUTATED GLIOMAS
    del Bufalo, Francesca
    Cacchione, Antonella
    Carai, Andrea
    Antonelli, Manila
    Giangaspero, Felice
    Ferretti, Elisabetta
    Catanzaro, Giuseppina
    Miele, Evelina
    Badiali, Manuela
    Pettorini, Benedetta
    Mastronuzzi, Angela
    [J]. NEURO-ONCOLOGY, 2016, 18 : 24 - 24
  • [8] The Mitochondrial Candidate: Effects of BAM15 on BRAFV600E Melanoma
    Rangel, C.
    Li, K.
    Chipuk, J.
    Serasinghe, M.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 : S264 - S265
  • [9] Modulation of MHC expression by BRAFV600E in melanoma
    Pollack, B. P.
    Sapkota, B.
    Hill, C. E.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S224 - S224
  • [10] Intrapatient Homogeneity of BRAFV600E Expression in Melanoma
    Menzies, Alexander M.
    Lum, Trina
    Wilmott, James S.
    Hyman, Jessica
    Kefford, Richard F.
    Thompson, John F.
    O'Toole, Sandra
    Long, Georgina V.
    Scolyer, Richard A.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (03) : 377 - 382